Replies to post #207602 on Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

In Chemistry we learned naltrexone competes with ALL opiods for the bodies opiod receptors. Leaving opiod equal to a placebo.
FDA likes the Pharmalogical approach to abuse deterrence.
Watch what happens before July 14.
This may help explain it:

GL